ARCHIVES

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

UICC Announces Grant Programs to Continue

April 15, 1977

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Beckman Coulter Offers Immunoassay System.

July 27, 2001

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010